(Q36112029)

English

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

quality of life

1 reference

based on heuristic

inferred from title

author name string

P Wimberger

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

H Gilet

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A-K Gonschior

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M M Heiss

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Moehler

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

G Oskay-Oezcelik

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

S-E Al-Batran

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

B Schmalfeldt

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A Schmittel

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

E Schulze

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

S L Parsons

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 June 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1979-1985

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

Malignant ascites: systematic review and guideline for treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

Malignant ascites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

Endpoints in cancer clinical trials: is there a need for measuring quality of life?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 October 2017

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 July 2018

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 July 2018

Malignant ascites. Clinical and experimental observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

2 July 2018

Malignant ascites symptom cluster in patients referred for paracentesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

23 September 2018

Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403730

23 September 2018

Identifiers

10.1093/ANNONC/MDS178

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36112029&oldid=1867655685"